Article Text

Download PDFPDF
Switch off the light on cycling, switch off the light on doping
  1. G Lippi1,
  2. M Franchini2,
  3. G Cesare Guidi1
  1. 1
    Sezione di Chimica Clinica, Dipartimento di Scienze Morfologico-Biomediche, Universitè di Verona, Italy
  2. 2
    Servizio di Immunoematologia e Trasfusione, Azienda Ospedaliera di Verona, Italy
  1. Professor G Lippi, MD, Sezione di Chimica Clinica, Dipartimento di Scienze Morfologico-Biomediche, Universitè degli Studi di Verona, Ospedale Policlinico GB Rossi, Piazzale Scuro, 10, 37134 Verona, Italy; ulippi{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

There is rather a long history of fraud in sport competitions, and doping has plagued the Tour de France almost since its beginning in 1903, culminating on 13 July, 1967 with the dramatic death of British cyclist Tom Simpson on the climb of Mont Ventoux, attributed to the use of amphetamines and complicated by the now defunct practice of drinking as little as possible.1 Nearly a year after the 2006 “Tour de Chaos”, when nine riders who were implicated in an international doping probe based on blood transfusions were ruled out of the race and the winner of the yellow jersey tested positive for testosterone,2 a sequence of events again plagued the 2007 competition. First, a German rider was tested non-negative for testosterone in an out-of-competition antidoping control a few days before the start of the race. Then, an Italian rider tested “non-negative” in a doping test for testosterone after stage 11 and a Spanish rider was found guilty of …

View Full Text


  • Competing interests: None.